BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 550146)

  • 1. Prostaglandins and drug induced agranulocytosis, aplastic anaemia and leukemia.
    Das UN
    Prostaglandins Med; 1979 Mar; 2(3):235-8. PubMed ID: 550146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis, aplastic anemia, and leukemia: relevance to arachidonic acid metabolism.
    Das UN
    Prostaglandins Leukot Essent Fatty Acids; 1990 Mar; 39(3):217-20. PubMed ID: 2110677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of granulocytes induced by toxic agents.
    Van der Hoeven L; Chang JC
    Ann Clin Lab Sci; 1976; 6(5):415-22. PubMed ID: 970927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study.
    BMJ; 1988 Jul; 297(6643):262-5. PubMed ID: 2458161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
    Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
    Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.
    Vincent PC
    Drugs; 1986 Jan; 31(1):52-63. PubMed ID: 3940848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced anaemias.
    Girdwood RH
    Drugs; 1976; 11(5):394-404. PubMed ID: 782836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug induced white blood cells injury (antimitotic chemotherapy) and other drugs].
    Rumilly F; Witz F; Eisenmann JC; Lederlin P; Herbeuval R
    Therapie; 1982; 37(4):371-5. PubMed ID: 7135316
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs and the bone marrow.
    Treleaven J; Barrett J
    Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.
    Uetrecht J
    Crit Rev Toxicol; 1990; 20(4):213-35. PubMed ID: 2178625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
    Eur J Clin Pharmacol; 1983; 24(6):833-6. PubMed ID: 6884419
    [No Abstract]   [Full Text] [Related]  

  • 14. Analgesics, agranulocytosis, and aplastic anaemia.
    Doll R; Lunde PK; Moeschlin S
    Lancet; 1987 Jan; 1(8524):101. PubMed ID: 2879151
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug--induced bone marrow injury.
    Yunis AA
    Adv Intern Med; 1969; 15():357-76. PubMed ID: 4908623
    [No Abstract]   [Full Text] [Related]  

  • 16. Analgesics, agranulocytosis, and aplastic anaemia: a major case-control study.
    Lancet; 1986 Oct; 2(8512):899-900. PubMed ID: 2876332
    [No Abstract]   [Full Text] [Related]  

  • 17. [Agranulocytosis and aplastic anemia induced by drugs].
    Laporte JR
    Med Clin (Barc); 1987 Apr; 88(13):555-8. PubMed ID: 3295412
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood dyscrasias and mianserin.
    Adams PC; Robinson A; Reid MM; Vishu MC; Livingston M
    Postgrad Med J; 1983 Jan; 59(687):31-3. PubMed ID: 6866871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

  • 20. Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor.
    Sayag-Boukris V; Ziza JM; Brice P; Wechsler B
    Rev Rhum Engl Ed; 1997 Jan; 64(1):66. PubMed ID: 9051866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.